The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis (P5-1.004)
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
10.1212/wnl.98.18_supplement.1651